156 related articles for article (PubMed ID: 30178833)
21. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
Baekelandt M; Kristensen GB; Nesland JM; Tropé CG; Holm R
J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma.
Herod JJ; Eliopoulos AG; Warwick J; Niedobitek G; Young LS; Kerr DJ
Cancer Res; 1996 May; 56(9):2178-84. PubMed ID: 8616869
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells.
Xi Y; Nie X; Wang J; Gao L; Lin B
Biomed Res Int; 2020; 2020():3607436. PubMed ID: 32309430
[TBL] [Abstract][Full Text] [Related]
25. The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.
Skirnisdottir I; Seidal T; Åkerud H
Int J Oncol; 2016 Mar; 48(3):998-1006. PubMed ID: 26783205
[TBL] [Abstract][Full Text] [Related]
26. ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2.
Zhu H; Gan X; Jiang X; Diao S; Wu H; Hu J
J Exp Clin Cancer Res; 2019 Apr; 38(1):163. PubMed ID: 30987661
[TBL] [Abstract][Full Text] [Related]
27. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
Liu L; Yang K
Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
[TBL] [Abstract][Full Text] [Related]
28. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
[TBL] [Abstract][Full Text] [Related]
29. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
[TBL] [Abstract][Full Text] [Related]
30. DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosis.
Diebold J; Suchy B; Baretton GB; Blasenbreu S; Meier W; Schmidt M; Rabes H; Löhrs U
Virchows Arch; 1996 Nov; 429(4-5):221-7. PubMed ID: 8972757
[TBL] [Abstract][Full Text] [Related]
31. Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.
Chan WY; Cheung KK; Schorge JO; Huang LW; Welch WR; Bell DA; Berkowitz RS; Mok SC
Am J Pathol; 2000 Feb; 156(2):409-17. PubMed ID: 10666369
[TBL] [Abstract][Full Text] [Related]
32. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
33. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.
Liu L; Zeng Z; Yi J; Zuo L; Lv J; Yuan J; Lin Z; Luo R; Feng X
Cancer Biomark; 2019; 24(2):213-221. PubMed ID: 30614797
[TBL] [Abstract][Full Text] [Related]
35. Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.
Radović S; Babić M; Dorić M; Hukić A; Kuskunović S; Hadzismajlović A; Serdarević F
Bosn J Basic Med Sci; 2007 Aug; 7(3):205-11. PubMed ID: 17848143
[TBL] [Abstract][Full Text] [Related]
36. [Expressions of apoptosis-associated proteins in prostate carcinoma and their clinicopathological significance].
Zhang X; Li F; Jiang Y
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):193-6. PubMed ID: 12515134
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer.
Bauer JJ; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Moul JW
J Urol; 1996 Oct; 156(4):1511-6. PubMed ID: 8808919
[TBL] [Abstract][Full Text] [Related]
38. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
Cao LQ; Chen XM; Li X
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
[TBL] [Abstract][Full Text] [Related]
39. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
[TBL] [Abstract][Full Text] [Related]
40. [Expression of survivin gene and its relation with the expression of bcl-2 and bax protein in epithelial ovarian cancer].
Zhang SL; Zhao CQ; Lin B; Li Y; Gao H
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):203-6. PubMed ID: 12885364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
